𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

✍ Scribed by Paula Maguire; Sara Margolin; Johanna Skoglund; Xiao-Feng Sun; Jan-Åke Gustafsson; Anne-Lise Børresen-Dale; Annika Lindblom

Publisher
Springer US
Year
2005
Tongue
English
Weight
190 KB
Volume
94
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen and progesterone receptor gene
Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: A Spanish case-control study
✍ L.P. Fernández; R.L. Milne; E. Barroso; M. Cuadros; J.I. Arias; A. Ruibal; J. Be 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB 👁 1 views

## Abstract Estrogens, and to a lesser extent progesterones, influence the proliferation, differentiation and physiology of breast tissue as well as the development and progression of breast cancer. Genetic variants in the steroid hormone receptor genes __ESR1__ and __PGR__ (belonging to the nuclea

Haplotypes of the estrogen receptor beta
Haplotypes of the estrogen receptor beta gene and breast cancer risk
✍ Breast; Prostate Cancer Cohort Consortium 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 316 KB

## Abstract Exposure to exogenous (oral contraceptives, postmenopausal hormone therapy) and endogenous (number of ovulatory cycles, adiposity) steroid hormones is associated with breast cancer risk. Breast cancer risk associated with these exposures could hypothetically be modified by genes in the

Estrogen receptor mutations in breast ca
Estrogen receptor mutations in breast cancer
✍ S. A. W. Fuqua; G. C. Chamness; W. L. McGuire 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

It is fairly well accepted that the presence of estrogen receptor (ER) identifies those breast cancer patients with a lower risk of relapse and better overall survival [Clark and McGuire, 19881, and the measurement of ER has become a standard assay in the clinical management of breast cancer. Recept